Mecasermin Subcutaneous and Pneumococcal Conjugate Vaccine (13-Valent)
Determining the interaction of Mecasermin Subcutaneous and Pneumococcal Conjugate Vaccine (13-Valent) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mecasermin
Brand name: Increlex
Synonyms: Mecasermin
Generic Name: pneumococcal 13-valent vaccine
Brand name: Prevnar 13
Synonyms: Pneumococcal 13-valent conjugate vaccine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mecasermin Subcutaneous-Pneumococcal Conjugate Vaccine (7-Valent)
- Mecasermin Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Mecasermin Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Mecasermin Subcutaneous-Pneumovax 23
- Mecasermin Subcutaneous-PNV - Omega
- Mecasermin Subcutaneous-PNV Iron Polysaccharides, Folic Acid, DHA
- Pneumococcal Conjugate Vaccine (13-Valent)-Mechlorethamine (Systemic)
- Pneumococcal Conjugate Vaccine (13-Valent)-Mechlorethamine Intravenous
- Pneumococcal Conjugate Vaccine (13-Valent)-Meclicot
- Pneumococcal Conjugate Vaccine (13-Valent)-Meclizine
- Pneumococcal Conjugate Vaccine (13-Valent)-Meclizine Chewable Tablets
- Pneumococcal Conjugate Vaccine (13-Valent)-Meclizine Hydrochloride